NL-OMON43221已完成不适用
A single center, randomized, open-label, controlled, three-arm study to evaluate the effect of a new combined oral contraceptive (COC) containing 15 mg Estetrol (E4) and 3 mg Drospirenone (DRSP) and of two reference COCs containing either 30 mcg Ethinylestradiol (EE) and 150 mcg Levonorgestrel (LNG) or 20 mcg EE and 3 mg DRSP on endocrine function, metabolic control and hemostasis during 6 treatment cycles - E4/DRSP endocrine function, metabolic control and hemostasis study
Estetra SPR0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age: 18-50 years, inclusive, at time of signing informed consent
- •Body Mass Index: 18.0-30.0 kg/m2, inclusive, at time of screening visit
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Clinical trial on tooth pasteCTRI/2024/05/067935Sriveda Sattva Private Limited Sri Sri Tattva
进行中（未招募）
不适用
A single-center, open-label, controlled, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) as compared to a sequential oral contraceptive containing ethinylestradiol and levonorgestrel (SH D00264A) on plasma lipids, hemostatic variables, and carbohydrate metabolism in 60 healthy female volunteers aged 18-50 years over 7 treatment cycles - Metabolism study vs Triquilar 21+7ContraceptionEUCTR2004-001614-13-DESchering AG60
进行中（未招募）
1 期
RAPID-1 Diabetic Foot Ulcer Randomised Controlled StudyEUCTR2018-003596-36-GBBiotherapy Services Ltd.66
已完成
不适用
Randomised controlled trial of early versus late ureteric stent removal post kidney transplantISRCTN51276329Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge (UK)350
Unknown
3 期
Ivermectin Treatment Trial (ITT)COVID-19PACTR202102588777597AGOS STATE MINISTRY OF HEALTH240